Neofordex Unió Europea - islandès - EMA (European Medicines Agency)

neofordex

theravia - dexametason - mergæxli - barksterar til almennrar notkunar - meðferð við mörgum mergæxli.

Orgalutran Unió Europea - islandès - EMA (European Medicines Agency)

orgalutran

n.v. organon - ganirelix - reproductive techniques, assisted; ovulation induction; infertility, female - hinsveiflur og heilahimnubólur og hliðstæður - forvarnir gegn ótímabærum stökkbólguhormónshrörnun hjá konum sem gangast undir stýrð eggjastokkaörvun fyrir aðstoðaðan æxlunartækni. Í rannsóknum, orgalutran var notað við skal læknir hafa manna anti-örvandi hormón eða corifollitropin alfa, viðvarandi anti örvandi.

Epidyolex Unió Europea - islandès - EMA (European Medicines Agency)

epidyolex

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptics, - epidyolex er ætlað til að nota eins og venjulega meðferð krampa í tengslum við lennox gastaut (lgs) eða dravet heilkenni (ds), með clobazami, fyrir sjúklinga 2 ára og eldri.

Tecovirimat SIGA Unió Europea - islandès - EMA (European Medicines Agency)

tecovirimat siga

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - veirueyðandi lyf til almennrar notkunar - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.

Qdenga Unió Europea - islandès - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - fjölmörgum - bóluefni - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.